Growing community of inventors

Plano, TX, United States of America

Jung-Mo Ahn

Average Co-Inventor Count = 1.65

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 36

Jung-Mo AhnGanesh Raj (7 patents)Jung-Mo AhnRatna K Vadlamudi (2 patents)Jung-Mo AhnXiankai Sun (1 patent)Jung-Mo AhnJer-Tsong Hsieh (1 patent)Jung-Mo AhnZhi-Ping Liu (1 patent)Jung-Mo AhnMartin Beinborn (1 patent)Jung-Mo AhnJung-Mo Ahn (14 patents)Ganesh RajGanesh Raj (7 patents)Ratna K VadlamudiRatna K Vadlamudi (4 patents)Xiankai SunXiankai Sun (7 patents)Jer-Tsong HsiehJer-Tsong Hsieh (3 patents)Zhi-Ping LiuZhi-Ping Liu (2 patents)Martin BeinbornMartin Beinborn (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Texas System (14 from 5,445 patents)


14 patents:

1. 12378201 - Histone demethylase inhibitors for treating cancers

2. 12275685 - Oligo-benzamide analogs and their use in cancer treatment

3. 10618869 - Oligo-benzamide compounds and their use

4. 9856206 - Oligo-benzamide compounds and their use

5. 9458095 - Oligo-benzamide compounds and their use in treating cancers

6. 9394241 - Composition and method for making oligo-benzamide compounds

7. 9072705 - Oligo-benzamide compounds and their use in treating cancers

8. 8992886 - Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells

9. 8835493 - Oligo-benzamide compounds for use in treating cancers

10. 8754124 - Oligo-benzamide compounds and their use in treating cancers

11. 8618324 - Composition and method for making oligo-benzamide compounds

12. 8236983 - Composition and method for the treatment of diseases affected by apoptosis

13. 8034768 - Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

14. 7816324 - Composition and method for the treatment of diseases affected by a peptide receptor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…